225 related articles for article (PubMed ID: 24567436)
1. BRAF(V600E) mutation in a histiocytic sarcoma arising from hairy cell leukemia.
Michonneau D; Kaltenbach S; Derrieux C; Trinquand A; Brouzes C; Gibault L; North MO; Delarue R; Varet B; Emile JF; Brousse N; Hermine O
J Clin Oncol; 2014 Dec; 32(35):e117-21. PubMed ID: 24567436
[No Abstract] [Full Text] [Related]
2. [Failure of treatment with 2-chlorodeoxyadenosine in the course of hairy cell leukemia associated with malignant histiocytosis].
Jullien V; Peyrade F; Taillan B; Perrin C; Sanderson F; Guzman-Granier E; Michiels JF; Dujardin P
Rev Med Interne; 1999 Mar; 20(3):287-8. PubMed ID: 10216890
[No Abstract] [Full Text] [Related]
3. Hairy cell leukemia.
Dearden C
Best Pract Res Clin Haematol; 2015 Dec; 28(4):163-5. PubMed ID: 26614893
[No Abstract] [Full Text] [Related]
4. Discrepant results for BRAF V600E mutation among different specimens in a case of hairy cell leukemia.
Moon HW; Hur M; Han SH; Yun YM; Kim SY
Ann Lab Med; 2013 Jul; 33(4):300-3. PubMed ID: 23826570
[No Abstract] [Full Text] [Related]
5. BRAF inhibition in refractory hairy-cell leukemia.
Dietrich S; Glimm H; Andrulis M; von Kalle C; Ho AD; Zenz T
N Engl J Med; 2012 May; 366(21):2038-40. PubMed ID: 22621641
[No Abstract] [Full Text] [Related]
6. Dramatic response of a BRAF V600E-mutated primary CNS histiocytic sarcoma to vemurafenib.
Idbaih A; Mokhtari K; Emile JF; Galanaud D; Belaid H; de Bernard S; Benameur N; Barlog VC; Psimaras D; Donadieu J; Carpentier C; Martin-Duverneuil N; Haroche J; Feuvret L; Zahr N; Delattre JY; Hoang-Xuan K
Neurology; 2014 Oct; 83(16):1478-80. PubMed ID: 25209580
[No Abstract] [Full Text] [Related]
7. Second hematologic malignancies in hairy cell leukemia: report of two patients with dynamic mutations in the BRAF gene.
Filanovsky K; Yacobi R; Vorst E; Barshack I; Ustaev E; Feldberg E; Shvidel L
Leuk Lymphoma; 2015 Mar; 56(3):823-5. PubMed ID: 25029639
[No Abstract] [Full Text] [Related]
8. Rapid and complete hematological response of refractory hairy cell leukemia to the BRAF inhibitor dabrafenib.
Vergote V; Dierickx D; Janssens A; Verhoef G; Tousseyn T; Vandenberghe P; Wolter P; Delforge M
Ann Hematol; 2014 Dec; 93(12):2087-9. PubMed ID: 24863690
[No Abstract] [Full Text] [Related]
9. Targeted therapy of BRAF V600E-mutant histiocytic sarcoma: A case report and review of the literature.
Branco B; Comont T; Ysebaert L; Picard M; Laurent C; Oberic L
Eur J Haematol; 2019 Oct; 103(4):444-448. PubMed ID: 31376203
[No Abstract] [Full Text] [Related]
10. Molecular detection of BRAF-V600E is superior to flow cytometry for disease evaluation in hairy cell leukaemia.
Rider T; Powell R; Gover R; Ansell R; Bastow S; Ghurye RR; Stewart H; Chevassut T
Hematol Oncol; 2014 Sep; 32(3):158-61. PubMed ID: 24123063
[No Abstract] [Full Text] [Related]
11. Low-dose vemurafenib induces complete remission in a case of hairy-cell leukemia with a V600E mutation.
Peyrade F; Re D; Ginet C; Gastaud L; Allegra M; Ballotti R; Thyss A; Zenz T; Auberger P; Robert G
Haematologica; 2013 Feb; 98(2):e20-2. PubMed ID: 23300174
[No Abstract] [Full Text] [Related]
12. Continued response off treatment after BRAF inhibition in refractory hairy cell leukemia.
Dietrich S; Hüllein J; Hundemer M; Lehners N; Jethwa A; Capper D; Acker T; Garvalov BK; Andrulis M; Blume C; Schulte C; Mandel T; Meissner J; Fröhling S; von Kalle C; Glimm H; Ho AD; Zenz T
J Clin Oncol; 2013 Jul; 31(19):e300-3. PubMed ID: 23690412
[No Abstract] [Full Text] [Related]
13. [Detection of BRAF V600E mutation in hairy cell leukemia by high- resolution melting analysis].
Zhang Y; Liu H; Qi J; Liu W; Qiu L
Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):207-9. PubMed ID: 24666485
[TBL] [Abstract][Full Text] [Related]
14. Secondary histiocytic sarcoma with BRAF
Venkataraman V; Massoth LR; Sullivan RJ; Friedmann AM
Pediatr Blood Cancer; 2021 Oct; 68(10):e29166. PubMed ID: 34061432
[No Abstract] [Full Text] [Related]
15. Hairy cell leukemia: Past, present and future.
Getta BM; Park JH; Tallman MS
Best Pract Res Clin Haematol; 2015 Dec; 28(4):269-72. PubMed ID: 26614906
[TBL] [Abstract][Full Text] [Related]
16. Treatment of refractory hairy cell leukemia with a BRAF-inhibitor: lessons to be learnt.
Sári E; Nagy ZG; Baghy K; Rajnai H; Bödör C; Csomor J; Barna G; Rudas G; Kovalszky I; Demeter J
Pathol Oncol Res; 2014 Oct; 20(4):973-80. PubMed ID: 24789721
[TBL] [Abstract][Full Text] [Related]
17. Hairy cell leukemia: update and current therapeutic approach.
Salam L; Abdel-Wahab O
Curr Opin Hematol; 2015 Jul; 22(4):355-61. PubMed ID: 26049757
[TBL] [Abstract][Full Text] [Related]
18. Pyrosequencing of BRAF V600E in routine samples of hairy cell leukaemia identifies CD5+ variant hairy cell leukaemia that lacks V600E.
Lennerz JK; Klaus BM; Marienfeld RB; Möller P
Br J Haematol; 2012 Apr; 157(2):267-9. PubMed ID: 22145942
[No Abstract] [Full Text] [Related]
19. Hairy cell leukemia: a 'hair-raising' update.
Topp ZZ; Saven A
Expert Rev Hematol; 2014 Oct; 7(5):659-69. PubMed ID: 25148599
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and molecular characteristics and prognosis of classical hairy cell leukemia and hairy cell leukemia variant].
Wei C; Jin XX; Cai H; Wang X; Zhuang JL; Zhou DB
Zhonghua Nei Ke Za Zhi; 2023 Apr; 62(4):416-421. PubMed ID: 37032137
[No Abstract] [Full Text] [Related]
[Next] [New Search]
